Charles Lin, Ph.D.
Baylor College of Medicine
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR150093|
Recruitment of First-Time, Tenure-Track Faculty Members
Dana-Farber Cancer Institute
August 19, 2015
Cancer is fundamentally a disease that alters the programming of genes. It corrupts the normal processes that create the diversity of cells in the human body and produces cells that multiply uncontrollably and invade normal tissues.
Key drivers for cancer are oncogenes and tumor suppressor genes, both of which act as genetic on or off switches, and when mutated, can cause cancer.
Charles Lin’s research combines molecular, computational, and chemical biology approaches to study gene control in cancer. He was recruited to Baylor College of Medicine, Department of Molecular and Human Genetics, from the Dana-Farber Cancer Institute, where he was a postdoctoral fellow. A First-Time Tenure-Track Award from CPRIT in 2015 lured Lin back to Texas; he is originally from San Antonio. Lin cofounded and co-directs the Therapeutic Innovation Center at Baylor.